Dr. Christine Klemens was awarded a highly competitive K99 grant from the NIH NHLBI section to study the role of an understudied chloride transporter, ClC-6, in renal and vascular function during hypertension. These studies will provide further mechanistic insight to the role of this protein in blood pressure regulation in normotensive and pathological conditions. Dr. Klemens received her PhD from the University of Pittsburgh and was previously a postdoctoral fellow at the Medical College of Wisconsin. She is currently a Research Associate under the mentorship of Dr. Alexander Staruschenko, the current director of the Hypertension and Kidney Research Center, part of the USF School of Medicine Heart Institute.
Dr. DaZhi Wang was invited to give a seminar at the Stanford Cardiovascular Institute, Stanford University, on Jan 18, 2022. The title of his presentation was "Molecular Regulation of Cardiac Function, Regeneration and Disease." This archived talk is available for viewing here: https://med.stanford.edu/cvi/events/frontiers-in-cv-science/seminar-videos-2022.html.
We would like to congratulate Dr. Jerome Breslin, who has been elected as President-Elect of the Microcirculatory Society. The link to the Microcirculatory Society’s website is listed here for reference: https://www.microcirc.org/ . Dr. Breslin will lead the Microcirculatory Society in its mission to “actively encourage and promote all forms of innovative research and teaching, leading to an increase in understanding of microcirculatory function in health and disease.” This is a prestigious honor and we are very proud to have Dr. Breslin on our team. Congratulations!
Professor, USF Health Heart Institute
Vice Dean for Research, Morsani College of Medicine
Associate Vice President for Research, USF Health
Professor of Internal Medicine
Associate Professor, USF Health Heart Institute
Mutations in the LMNA gene (encoding lamin A/C) are a significant cause of familial arrhythmogenic cardiomyopathy. Although the penetrance is high, there is considerable phenotypic variability in disease onset, rate of progression, arrhythmias, and severity of myopathy. To begin to address whether this variability stems from specific LMNA mutation sites and types, we generated seven patient-specific induced pluripotent stem cell (iPSC) lines with various LMNA mutations.